Barely Significant
← all excerpts

A multimodal approach for establishing <i>ACTL6A</i> and <i>ERCC1</i> as chemoresistance genes in locally advanced head and neck cancer.

Front Pharmacol · 2025 · PMC12159016 · PMID 40510426

Europe PMCDOI
1
hedged sentence
0.0030
closest p · 0.1× alpha
0.0030
boldest claim

The sentences

marginally significantp = 0.003actually significant
We also found significant and marginally significant correlations between ERCC1 and ACTL6A expressions after 50% ( p = 0.003) and 100% ( p = 0.06) CCRT, respectively, among the HNC patients, which supports the hypothesis of ACTL6A-mediated NER activation.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.